Life situation, coping and quality of life in people with high and low risk of developing Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 16, Issue 4, 2003, Pages 220-228

  Axelman, Karin ^a   Lannfelt, Lars ^b   Almkvist, Ove ^a   Carlsson, Marianne ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alzheimer's disease; Coping; Heredity; Life situation; Quality of life

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COPING BEHAVIOR; EMOTIONAL ATTACHMENT; FEMALE; HEREDITY; HIGH RISK POPULATION; HUMAN; HUMAN RELATION; LIFE EVENT; MALE; MEDICAL INFORMATION; MEDICAL LITERATURE; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SOCIAL SUPPORT; SYMPTOM;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS;

EID: 0141728453     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072806     Document Type: Article

References (40)

1. Kokmen E, Chandra V, Schoenberg B: Trends in incidence of dementing illness in Rochester, Minnesota in three quinquennial periods, 1960-1974. Neurology 1988;38:975-980.
2. Fratiglioni L, Grut M, Forsell Y, et al: Prevalence of Alzheimer's disease and other dementias in an elderly urban population: Relationship with age, sex, and education. Neurology 1991;41:1886-1892.
3. Copeland JR, Davidson IA, Dewey ME, et al: Alzheimer's disease, other dementias, depression and pseudodementia: Prevalence, incidence and three-year outcome in Liverpool. Br J Psychiatry 1992;161:230-239.
4. Skoog I, Nilsson L, Palmertz B, et al: A population-based study of dementia in 85-year-olds. N Engl J Med 1993;328:153-158.
5. Sjögren T, Sjögren H, Lindgren Å.: Morbus Alzheimer and morbus Pick: A genetic, clinical and patho-anatomical study. Acta Psychiatr Neurol Scand 1952;Suppl 82:1-152.
6. Breitner J, Silverman J, Mohs R, Davis K: Familial aggregation in Alzheimer's disease: Comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations. Neurology 1988;38:207-212.
7. Nee LE, Polinsky RJ, Eldridge R, et al: A family with historically confirmed Alzheimer's disease. Arch Neurol 1983;40:203-208.
8. Mohs R, Breitner J, Silverman J: Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age. Arch Gen Psychiatry 1987;44:405-408.
9. Farrer LA, Cupples LA, van Duijn CM, et al: Apolipoprotein E genotype in patients with Alzheimer's disease: Implications for risk of dementia among relatives. Ann Neurol 1995;38:797-808.
10. Chartier-Harlin M-C, Crawford F, Houlden H, et al: Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991;353:844-846.
11. Murrell J, Farlow M, Ghette B, Benson MD: A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 1991;254:97-99.
12. Hendriks L, van Duijn C, Cras P, et al: Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat Genet 1992;1:218-221.
13. Mullan M, Crawford F, Axelman K, et al: A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat Genet 1992;1:345-347.
14. Nilsberth C, Westlind-Danielsson A, Eckman C, et al: The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enchanced Abeta protofibril formation. Nat Neurosci 2001;4:887-893.
15. Sherrington R, Rogaev EI, Liang Y, et al: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-760.
16. Clark RF, Hutton M, Fuldner RA, et al: The structure of the presenilin I (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet 1995;11:219-222.
17. Campion D, Flaman J-M, Brice A, et al: Mutations of the presenilin 1 gene in families with early-onset Alzheimer's disease. Hum Mol Genet 1995;4:2373-2377.
18. Cruts M, Backhovens H, Wang SY, et al: Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum Mol Genet 1995;4:2363-2371.
19. Levy-Lahad E, Wijsman E, Nemens E, et al: A familial Alzheimer's disease locus on chromosome 1. Science 1995;269:970-973.
20. Saunders AM, Strittmatter WJ, Schmechel D, et al: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
21. Strittmatter WJ, Weisgraber KH, Huang DY, et al: Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:8098-8102.
22. Corder EH, Saunders AM, Strittmatter WJ, et al: Gene dose of apolipoprotein E type 4 allele and risk of Alzheimer's disease in late-onset families. Science 1993;261:921-923.
23. Wiggins S, Whyte P, Huggins M, et al: The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med 1992;327:1401-1405.
24. Codori A, Brandt J: Psychological costs and benefits of predictive testing for Huntington's disease. Am J Med Genet 1994;54:174-184.
25. Lannfelt L, Axelman K, Lilius L, Basun H: Genetic counselling in a Swedish Alzheimer family with amyloid precursor protein mutation. Am J Hum Genet 1995;56:332-335.
26. Robins Wahlin T-B, Lundin A, Bäckman L, et al: Reactions to predictive testing in Huntington disease: Case reports of coping with a new genetic status. Am J Med Genet 1997;73:356-365.
27. Swearer JM, O'Donnell BF, Kane KJ, Drachman DA: Psychological features in persons at risk for familial Alzheimer's disease. Am J Alzheimer's Dis Other Demen 2001;16:157-162
28. Anderson RT, Aaronson NK, Wilken D: Critical review of the international assessments of health-related quality of life. Qual Life Res 1993;2:369-395.
29. Lindqvist R, Carlsson M, Po S: Coping strategies and styles assessed by the Jalowiec Coping Scale in a random sample of the Swedish population. Scand J Caring Sci 2000;14:147-154.
30. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ARDRA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984;34:939-943.
31. Jalowiec A: Psychometric results on the 1987 Jalowiec Coping Scale; in: School of Nursing. Chicago, Loyola University, 1991.
32. Carlsson M, Hamrin E: Measurement of quality of life in women with breast cancer. Development of a Life Satisfaction Questionnaire (LSQ-32) and a comparison with the EORTC QLQ-C30. Qual Life Res 1996;5:265-274.
33. Carlsson M, Hamrin E, Lindqvist R: Psychometric assessment of Life Satisfaction Questionnaire (LSQ) and a comparison of a randomised sample of Swedish women and those suffering from breast cancer. Qual Life Res 1999;8:245-253.
34. Gorsuch R: Factor Analysis. New Jersey, Erlbaum, 1983.
35. Likert RA: A technique for the Measurement of Attitudes. New York, Archives of Psychology, 1932.
36. Cronbach LJ: Coefficient alpha and the internal structure of test. Psychometrika 1951;16:297-334.
37. Hepburn K, Tornatore J, Ostwald S: Dementia family caregiver training: Affecting beliefs about caregiving and caregiver outcomes. J Am Geriatr Soc 2001;49:450-457.
38. Sadovnick A: Genetic counselling and genetic screening for Alzheimer's disease and other dementias. Can J Neurol Sci 2001;28:52-55.
39. Lerman C, Narod S, Schulman K, et al: BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA 1996;275:1885-1892.
40. Evans DGR, Maher ER, Macleod R, Davies DR, Craufurd D: Uptake of genetic testing for cancer predisposition - Ethical issues. J Med Genet 1997;34:756-748.